Stephanie Christopher
Overview
Explore the profile of Stephanie Christopher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaudhuri S, Ben Chaouch Z, Hauber B, Mange B, Zhou M, Christopher S, et al.
J Biopharm Stat
. 2023 Mar;
:1-20.
PMID: 36861942
A fixed one-sided significance level of 5% is commonly used to interpret the statistical significance of randomized clinical trial (RCT) outcomes. While it is necessary to reduce the false positive...
2.
Benz H, Caldwell B, Ruiz J, Saha A, Ho M, Christopher S, et al.
MDM Policy Pract
. 2021 Jul;
6(1):23814683211021380.
PMID: 34277950
A growing literature has developed on identifying outcomes that matter to patients. This study demonstrates an approach involving patient and regulatory perspectives to identify outcomes that are meaningful in the...
3.
Hauber B, Mange B, Zhou M, Chaudhuri S, Benz H, Caldwell B, et al.
MDM Policy Pract
. 2021 Feb;
6(1):2381468320978407.
PMID: 33521289
Parkinson's disease (PD) is neurodegenerative, causing motor, cognitive, psychological, somatic, and autonomic symptoms. Understanding PD patients' preferences for novel neurostimulation devices may help ensure that devices are delivered in a...
4.
Levitan B, Hauber A, Damiano M, Jaffe R, Christopher S
Patient
. 2017 Aug;
10(5):531-536.
PMID: 28831745
No abstract available.
5.
Ho M, Saha A, McCleary K, Levitan B, Christopher S, Zandlo K, et al.
Value Health
. 2016 Oct;
19(6):746-750.
PMID: 27712701
Background: In response to 2012 guidance in which the US Food and Drug Administration's (FDA) Center for Devices and Radiological Health (CDRH) stated the importance of patient-centric measures in regulatory...
6.
Farrell M, Speiser J, Deuster L, Christopher S
Arch Pediatr Adolesc Med
. 2012 Jan;
166(1):62-7.
PMID: 22213752
Objective: To demonstrate a quantitative abstraction method for Communication Quality Assurance projects to assess physicians' communication about hidden emotions after newborn genetic screening. Design: Communication quality indicator analysis. Setting: Standardized...
7.
Farrell M, Deuster L, Donovan J, Christopher S
Pediatrics
. 2008 Aug;
122(2):243-9.
PMID: 18676539
Objective: The goal was to investigate pediatric residents' usage of jargon during discussions about positive newborn screening test results. Methods: An explicit-criteria abstraction procedure was used to identify jargon usage...
8.
Deuster L, Christopher S, Donovan J, Farrell M
J Gen Intern Med
. 2008 Aug;
23(12):1947-52.
PMID: 18670828
Background: Jargon is a barrier to effective patient-physician communication, especially when health literacy is low or the topic is complicated. Jargon is addressed by medical schools and residency programs, but...